Acute Kidney Injury in Patients with Non-Valvular Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-Based Study from the United Kingdom.
Antonio Gonzalez PerezYanina BalabanovaMaría Eugenia SáezGunnar BrobertLuis Alberto García-RodríguezPublished in: Clinical epidemiology (2022)
Our results support a beneficial effect of rivaroxaban over warfarin in terms of AKI occurrence in patients with NVAF. More research into how best to define AKI using primary care records would be valuable for future studies.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- acute kidney injury
- primary care
- direct oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- risk assessment
- heart failure
- current status
- percutaneous coronary intervention
- venous thromboembolism
- case control
- general practice
- acute coronary syndrome
- left ventricular
- pulmonary embolism
- mitral valve
- coronary artery disease